Related Experiment Video
Updated: Apr 11, 2026

Passive Administration of Monoclonal Antibodies Against H. capsulatum and Others Fungal Pathogens
Published on: February 14, 2011
Histoplasma capsulatum, lung infection and immunity
Michael C Horwath1,2, Roger A Fecher1,2, George S Deepe1,3
1Division of Infectious Diseases, University of Cincinnati College of Medicine, 3230 Eden Ave, Cincinnati, OH 45267, USA.
Histoplasma capsulatum causes lung infections, especially in immunocompromised individuals. Understanding immune responses in mouse models helps predict disease severity with new immunosuppressive drugs.
Area of Science:
- Mycology
- Immunology
- Infectious Diseases
Background:
- Histoplasma capsulatum is a common cause of endemic pulmonary mycosis in the USA.
- Disease manifestations are most frequent in immunocompromised patients residing in endemic regions.
Purpose of the Study:
- To elucidate the mechanisms of fungal recognition and immune responses (innate and adaptive) to Histoplasma capsulatum.
- To correlate these mechanisms with disease protection or exacerbation.
- To inform clinical vigilance regarding novel immunosuppressive agents.
Main Methods:
- Review of clinical observations and murine studies.
- Utilizing mice as a model system to investigate immune responses to H. capsulatum.
- Examining the impact of immunomodulatory drugs on the immune response.
Main Results:
- The study outlines key mechanisms of fungal recognition by the host immune system.
- It details the interplay between innate and adaptive immunity in Histoplasma infection.
- Murine models provide insights into disease pathogenesis and host-pathogen interactions.
Conclusions:
- Understanding immune pathways is crucial for predicting and managing histoplasmosis.
- Novel immunosuppressive agents targeting identified pathways require careful consideration.
- Continued research combining clinical data and murine models is essential for advancing knowledge.
More Related Videos
07:21Processing of Bronchoalveolar Lavage Fluid and Matched Blood for Alveolar Macrophage and CD4+ T-cell Immunophenotyping and HIV Reservoir Assessment
Published on: June 23, 2019
10:10A 3D Human Lung Tissue Model for Functional Studies on Mycobacterium tuberculosis Infection
Published on: October 5, 2015
Related Concept Videos
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Atypical Pneumonia
Cell-mediated Immune Responses
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...